Richard has made over 22 trades of the Exact Sciences stock since 2013, according to the Form 4 filled with the SEC. Most recently Richard exercised 1,125 units of EXAS stock worth $72,135 on 15 June 2019.
The largest trade Richard's ever made was exercising 20,000 units of Exact Sciences stock on 23 September 2016 worth over $738,400. On average, Richard trades about 2,548 units every 53 days since 2003. As of 15 June 2019 Richard still owns at least 13,673 units of Exact Sciences stock.
You can see the complete history of Richard Barker stock trades at the bottom of the page.
Richard's mailing address filed with the SEC is C/O CELGENE CORPORATION, 86 MORRIS AVENUE, SUMMIT, NJ, 07901.
Over the last 21 years, insiders at Exact Sciences have traded over $118,141,352 worth of Exact Sciences stock and bought 191,930 units worth $1,451,887 . The most active insiders traders include Kevin T Conroy, Edwin M Jr Kania y Maneesh Arora. On average, Exact Sciences executives and independent directors trade stock every 12 days with the average trade being worth of $1,667,056. The most recent stock trade was executed by Brian Baranick on 5 August 2024, trading 2,712 units of EXAS stock currently worth $173,893.
exact sciences is a molecular diagnostics company focused on colorectal cancer. the company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. stool-based dna (sdna) technology is included in the colorectal cancer screening guidelines of the american cancer society and the u.s. multi-society task force on colorectal cancer. for more information on exact sciences' noninvasive colon cancer screening test, visit cologuardtest.com
Exact Sciences executives and other stock owners filed with the SEC include: